Part 4 — From Discovery to Delivery: How Scientists Are Revolutionizing Cancer Treatment
Part 4 — From Discovery to Delivery: How Scientists Are Revolutionizing Cancer Treatment  
Podcast: Science Will Win
Published On: Tue Nov 18 2025
Description: In drug discovery and development, every part of the process matters. Scientists learn from every experiment and every observation. In fact, some of the most cutting-edge advancements in medicine are being dreamed up from findings uncovered in the past.  In this episode, co-hosts Dr. Raven Baxter and Dr. Ronald Gamble dive deep into antibody drug conjugates, a groundbreaking modality that uses targeted antibody engineering to deliver potent chemotherapy directly to cancer-causing cells. They explore the complex ADC creation process and learn how ADCs are changing the standard of care for bladder cancer, from someone with a personal relationship to the disease.Featured Guests:– Renee Barron-Gores, Caregiver– Phoenix Ho, Vice President, Oncology Early Clinical Development, Pfizer– Sharsti Sandall, Executive Director, ADC Biology, Oncology Research Unit, PfizerDive into the episode here:1:16 - Old ideas yield new discoveries3:01 - How do antibody drug conjugates work?5:07 - The origins of ADCs8:36 - ADCs allow for more targeted cancer treatment10:44 - How are ADCs structured?14:16 - How do scientists find the best ADC combinations?18:27 - Developing oncology drugs22:02 - ADCs and bladder cancer24:28 - A caregiver’s perspective on cancer treatment38:12 - Science Will WinSeason 5 of Science Will Win is created by Pfizer and hosted by Dr. Raven Baxter and Dr. Ronald Gamble. It’s produced by Acast Creative Studios.Check out our social media platforms to take a deeper look into the labs and stories we discuss during the episodes: Instagram (@pfizerinc), TikTok (@pfizer) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.